140 related articles for article (PubMed ID: 38690418)
1. Discussion to: Use of a novel microbiome modulator improves anticancer immunity in a murine model of malignant pleural mesothelioma.
JTCVS Open; 2024 Apr; 18():345-346. PubMed ID: 38690418
[No Abstract] [Full Text] [Related]
2. Use of a novel microbiome modulator improves anticancer immunity in a murine model of malignant pleural mesothelioma.
Gattlen C; Frank KR; Marie DN; Trompette A; Chriqui LE; Hao Y; Abdelnour E; Gonzalez M; Krueger T; Dyson PJ; Siankevich S; von Garnier C; Ubags NDJ; Cavin S; Perentes JY
JTCVS Open; 2024 Apr; 18():324-344. PubMed ID: 38690424
[TBL] [Abstract][Full Text] [Related]
3. Synergistic antitumor effects of regulatory T cell blockade combined with pemetrexed in murine malignant mesothelioma.
Anraku M; Tagawa T; Wu L; Yun Z; Keshavjee S; Zhang L; Johnston MR; de Perrot M
J Immunol; 2010 Jul; 185(2):956-66. PubMed ID: 20548032
[TBL] [Abstract][Full Text] [Related]
4. Newly synthesized anticancer drug HUHS1015 is effective on malignant pleural mesothelioma.
Kaku Y; Nagaya H; Tsuchiya A; Kanno T; Gotoh A; Tanaka A; Shimizu T; Nakao S; Tabata C; Nakano T; Nishizaki T
Cancer Sci; 2014 Jul; 105(7):883-9. PubMed ID: 24754309
[TBL] [Abstract][Full Text] [Related]
5. Malignant pleural mesothelioma.
Kindler HL
Curr Treat Options Oncol; 2000 Oct; 1(4):313-26. PubMed ID: 12057157
[TBL] [Abstract][Full Text] [Related]
6. ER Stress Response and Induction of Apoptosis in Malignant Pleural Mesothelioma: The Achilles Heel Targeted by the Anticancer Ruthenium Drug BOLD-100.
Ranzato E; Bonsignore G; Martinotti S
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077664
[TBL] [Abstract][Full Text] [Related]
7. Antitumor impact of interferon-γ producing CD1d-restricted NKT cells in murine malignant mesothelioma.
Tagawa T; Wu L; Anraku M; Yun Z; Rey-McIntyre K; de Perrot M
J Immunother; 2013 Oct; 36(8):391-9. PubMed ID: 23994885
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel-loaded expansile nanoparticles improve survival following cytoreductive surgery in pleural mesothelioma xenografts.
Chu NQ; Liu R; Colby A; de Forcrand C; Padera RF; Grinstaff MW; Colson YL
J Thorac Cardiovasc Surg; 2020 Sep; 160(3):e159-e168. PubMed ID: 32044093
[TBL] [Abstract][Full Text] [Related]
9. Malignant pleural fluid from mesothelioma has potent biological activities.
Cheah HM; Lansley SM; Varano Della Vergiliana JF; Tan AL; Thomas R; Leong SL; Creaney J; Lee YC
Respirology; 2017 Jan; 22(1):192-199. PubMed ID: 27560254
[TBL] [Abstract][Full Text] [Related]
10. [A case of remission in diffuse pleural mesothelioma induced by anticancer chemotherapy with cisplatin and adriamycin].
Kinoshita S; Yamashita T; Yagi M; Bando H; Tsubura E; Sano T
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1872-6. PubMed ID: 4041164
[TBL] [Abstract][Full Text] [Related]
11. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.
Bibby AC; Tsim S; Kanellakis N; Ball H; Talbot DC; Blyth KG; Maskell NA; Psallidas I
Eur Respir Rev; 2016 Dec; 25(142):472-486. PubMed ID: 27903668
[TBL] [Abstract][Full Text] [Related]
12. Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study.
Capkova L; Koubkova L; Kodet R
Neoplasma; 2014; 61(2):161-9. PubMed ID: 24471939
[TBL] [Abstract][Full Text] [Related]
13. Malignant cells from pleural fluids in malignant mesothelioma patients reveal novel mutations.
Sneddon S; Dick I; Lee YCG; Musk AWB; Patch AM; Pearson JV; Waddell N; Allcock RJN; Holt RA; Robinson BWS; Creaney J
Lung Cancer; 2018 May; 119():64-70. PubMed ID: 29656754
[TBL] [Abstract][Full Text] [Related]
14. [Gemcitabine improved QOL and survival in a case of diffuse malignant pleural mesothelioma].
Kawamata O; Uda M; Mori M; Urakubo N; Hamano R; Oota T
Gan To Kagaku Ryoho; 2003 Apr; 30(4):551-4. PubMed ID: 12722691
[TBL] [Abstract][Full Text] [Related]
15. Assessment of cell-mediated immunity to malignant mesothelioma by microcytotoxicity tests.
Embleton MJ; Wagner JC; Wagner MM; Jones JS; Sheers G; Oldham PD; Baldwin RW
Int J Cancer; 1976 May; 17(5):597-601. PubMed ID: 1270175
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for malignant pleural mesothelioma: current status and future directions.
Dozier J; Zheng H; Adusumilli PS
Transl Lung Cancer Res; 2017 Jun; 6(3):315-324. PubMed ID: 28713676
[TBL] [Abstract][Full Text] [Related]
17. Malignant pleural mesothelioma: when is radiation therapy indicated?
van Thiel ER; Surmont VF; van Meerbeeck JP
Expert Rev Anticancer Ther; 2011 Apr; 11(4):551-60. PubMed ID: 21504322
[TBL] [Abstract][Full Text] [Related]
18. Clinical course of human epithelial-type malignant pleural mesothelioma replicated in an orthotopic-transplant nude mouse model.
Colt HG; Astoul P; Wang X; Yi ES; Boutin C; Hoffman RM
Anticancer Res; 1996; 16(2):633-9. PubMed ID: 8687108
[TBL] [Abstract][Full Text] [Related]
19. [Video-assisted thoracoscopic surgery in diagnostic and treatment of non-operable malignant pleural mesothelioma].
Murdzhev K; Uchikov A; Iankulov A; Paskalev G
Khirurgiia (Sofiia); 2007; (4):23-6. PubMed ID: 18443531
[TBL] [Abstract][Full Text] [Related]
20. Pleural-based mesothelioma in immune competent rats: a model to study adenoviral gene transfer.
Kucharczuk JC; Elshami AA; Zhang HB; Smythe WR; Hwang HC; Tomlinson JS; Amin KM; Litzky LA; Albelda SM; Kaiser LR
Ann Thorac Surg; 1995 Sep; 60(3):593-7; discussion 597-8. PubMed ID: 7677485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
